Benitec Biopharma Inc. (BNTC) Stock Ticker
BNTC right now
Market factors today
Unlock the full BNTC picture
About Benitec Biopharma Inc.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
BNTC stock facts
| Ticker symbol | BNTC |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $329.5M |
| CEO | Jerel A. Banks |
| Employees | 24 |
| Headquarters | Hayward, CA, US |
| IPO date | 2014-06-24 |
| Website | benitec.com |
What you can see for BNTC on Tickr
Live BNTC price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BNTC report.
Rankings
FAQ
What is the ticker symbol for Benitec Biopharma Inc.?
The ticker symbol for Benitec Biopharma Inc. is BNTC, listed on the NASDAQ Capital Market.
What is BNTC?
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single…